Although HGF/c‐MET pathway was deemed as a promising therapeutic target, numerous investigations have proven that inhibition of HGF or c‐Met TKI was not an effective and practical therapeutic strategy in suppressing multiple human cancers.60, 61, 62, 63. This evidence concerns the gene MET and cancer.